scispace - formally typeset
C

Cholsoon Jang

Researcher at University of California, Irvine

Publications -  88
Citations -  6775

Cholsoon Jang is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 32, co-authored 56 publications receiving 4236 citations. Previous affiliations of Cholsoon Jang include KAIST & Harvard University.

Papers
More filters
Journal ArticleDOI

Glucose feeds the TCA cycle via circulating lactate.

TL;DR: It is found that lactate can be a primary source of carbon for the TCA cycle and thus of energy, and during the fasted state, the contribution of glucose to tissue TCA metabolism is primarily indirect (via circulating lactate) in all tissues except the brain.
Journal ArticleDOI

Metabolomics and Isotope Tracing

TL;DR: The basics of metabolite measurement by MS are described, including sample preparation, metabolomic analysis, and data interpretation, and the ways in which metabolomics and isotope tracing can illuminate biology are highlighted.
Journal ArticleDOI

Cardiac angiogenic imbalance leads to peripartum cardiomyopathy

TL;DR: The data indicate that PPCM is mainly a vascular disease, caused by excess anti-angiogenic signalling in the peripartum period, and explain how late pregnancy poses a threat to cardiac homeostasis, and why pre-eclampsia and multiple gestation are important risk factors for the development of P PCM.
Journal ArticleDOI

The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids

TL;DR: It is proposed that the small intestine shields the liver from otherwise toxic fructose exposure, finding that dietary fructose is cleared by theSmall intestine, both by prior exposure to fructose and by feeding.
Journal ArticleDOI

A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance

TL;DR: PPARGC1a is leveraged, a transcriptional coactivator that regulates broad programs of fatty acid consumption, to identify 3-hydroxyisobutyrate (3-HIB), a catabolic intermediate of the BCAA valine, as a new paracrine regulator of trans-endothelial fatty acid transport, providing a mechanistic explanation for how increased BCAA catabolic flux can cause diabetes.